ACE2 Expression Lentivector
Quickly and reliably create cells expressing ACE2 to advance your studies of the receptor's role in SARS-CoV-2 infection and normal physiology.
- Leverage SBI's robust lentivector expression technology to study the ACE2 receptor
- Choose ready-to-package plasmid or ready-to-transduce virus
- Also available as a stable HEK293 cell line
Products
| Catalog Number | Description | Size | Price | Quantity | Add to Cart | |||
|---|---|---|---|---|---|---|---|---|
| CVD19-100PA-1 | ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro Plasmid | 10 µg | $755 |
|
||||
| CVD19-100VA-1 | ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro Pre-packaged Virus | >2 x 10^6 IFUs | $755 |
|
||||
Overview
Overview
Advance your COVID-19 studies with SBI
SBI is helping scientists around the globe respond to the ongoing COVID-19 pandemic with research tools that get your studies up and running quickly and efficiently. Our ACE2 Expression Lentivector is based on our robust pCDH-CMV-MCS-EF1α-Puro Cloning and Expression Lentivector (Cat.# CD510B-1/VA-1), and delivers ACE2 expression from the CMV promoter, with a separate EF1α promoter driving the expression of the puromycin resistance gene for selection. Available in both plasmid and pre-packaged lentivirus formats, the ACE2 Expression Lentivector enables a wide range of studies using the systems of your choice.- Leverage SBI's robust lentivector expression technology to study the ACE2 receptor
- Choose ready-to-package plasmid or ready-to-transduce virus
- Also available as a stable HEK293 cell line
See all of our COVID-19-related Expression Constructs
| Catalog Number | Product name |
|---|---|
| CVD19-100PA/VA-1 | ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro (Plasmid or Pre-packaged Lentivirus) |
| CVD19-140PA/VA-1 | NRP1 Expression Lentivector, pCDH-CMV-NRP1-EF1α-Neo (Plasmid or Pre-packaged Lentivirus) |
| CVD19-120PA/VA-1 | SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, pCDH-CMV-SARS-CoV-2-N-EF1α-Puro (Plasmid or Pre-packaged Lentivirus) |
| CVD19-130PA/VA-1 | SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1α-Puro (Plasmid or Pre-packaged Lentivirus) |
| CVD19-135PA/VA-1 | SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro (Plasmid or Pre-packaged Lentivirus) |
| CVD19-200A-1 | HEK293 ACE2 Stable Cell Line |
| CVD19-260A-1 | HEK293-ACE2-NRP1 Overexpression Stable Cell Line |
| CVD19-220A-1 | HEK293 "N" SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line |
| CVD19-420A-1 CVD19-425A-1 | "N" SARS-CoV-2 Nucleocapsid mRNA |
| CVD19-430A-1 CVD19-435A-1 | "S" SARS-CoV-2 Spike Glycoprotein mRNA |
| CVD19-440A-1 CVD19-445A-1 | "S" SARS-CoV-2 Spike Omicron mRNA |
References
How It Works
Supporting Data
Supporting Data
Figure 1. pCDH-CMV-ACE2-EF1α-Puro delivers robust ACE2 expression in HEK293 cells. We transduced the ACE2 Expression Lentivector (pCDH-CMV-ACE2-EF1α-Puro) into HEK293 cells, extracted total protein, and analyzed ACE2 expression via western blot. The parental HEK293 cells (negative control lane) display no ACE2 expression whereas HEK293 cells transduced with the ACE2 Expression demonstrate robust ACE2 expression. The positive control of HEK293 cells transfected with the ACE2 Expression Lentivector also displays robust expression.
FAQs
Resources
Citations
Related Products
ACE2 Expression Lentivector
$755.00
Products
| Catalog Number | Description | Size | Price | Quantity | Add to Cart | |||
|---|---|---|---|---|---|---|---|---|
| CVD19-100PA-1 | ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro Plasmid | 10 µg | $755 |
|
||||
| CVD19-100VA-1 | ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro Pre-packaged Virus | >2 x 10^6 IFUs | $755 |
|
||||
Overview
Overview
Advance your COVID-19 studies with SBI
SBI is helping scientists around the globe respond to the ongoing COVID-19 pandemic with research tools that get your studies up and running quickly and efficiently. Our ACE2 Expression Lentivector is based on our robust pCDH-CMV-MCS-EF1α-Puro Cloning and Expression Lentivector (Cat.# CD510B-1/VA-1), and delivers ACE2 expression from the CMV promoter, with a separate EF1α promoter driving the expression of the puromycin resistance gene for selection. Available in both plasmid and pre-packaged lentivirus formats, the ACE2 Expression Lentivector enables a wide range of studies using the systems of your choice.- Leverage SBI's robust lentivector expression technology to study the ACE2 receptor
- Choose ready-to-package plasmid or ready-to-transduce virus
- Also available as a stable HEK293 cell line
See all of our COVID-19-related Expression Constructs
| Catalog Number | Product name |
|---|---|
| CVD19-100PA/VA-1 | ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro (Plasmid or Pre-packaged Lentivirus) |
| CVD19-140PA/VA-1 | NRP1 Expression Lentivector, pCDH-CMV-NRP1-EF1α-Neo (Plasmid or Pre-packaged Lentivirus) |
| CVD19-120PA/VA-1 | SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, pCDH-CMV-SARS-CoV-2-N-EF1α-Puro (Plasmid or Pre-packaged Lentivirus) |
| CVD19-130PA/VA-1 | SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1α-Puro (Plasmid or Pre-packaged Lentivirus) |
| CVD19-135PA/VA-1 | SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro (Plasmid or Pre-packaged Lentivirus) |
| CVD19-200A-1 | HEK293 ACE2 Stable Cell Line |
| CVD19-260A-1 | HEK293-ACE2-NRP1 Overexpression Stable Cell Line |
| CVD19-220A-1 | HEK293 "N" SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line |
| CVD19-420A-1 CVD19-425A-1 | "N" SARS-CoV-2 Nucleocapsid mRNA |
| CVD19-430A-1 CVD19-435A-1 | "S" SARS-CoV-2 Spike Glycoprotein mRNA |
| CVD19-440A-1 CVD19-445A-1 | "S" SARS-CoV-2 Spike Omicron mRNA |
References
How It Works
Supporting Data
Supporting Data
Figure 1. pCDH-CMV-ACE2-EF1α-Puro delivers robust ACE2 expression in HEK293 cells. We transduced the ACE2 Expression Lentivector (pCDH-CMV-ACE2-EF1α-Puro) into HEK293 cells, extracted total protein, and analyzed ACE2 expression via western blot. The parental HEK293 cells (negative control lane) display no ACE2 expression whereas HEK293 cells transduced with the ACE2 Expression demonstrate robust ACE2 expression. The positive control of HEK293 cells transfected with the ACE2 Expression Lentivector also displays robust expression.